mergers-and-acquisitions News

Genco Rejects Diana's Takeover Bid, Citing Undervaluation
Mergers & Acquisitions
3w ago

Genco Rejects Diana's Takeover Bid, Citing Undervaluation

Shares rise as the dry bulk shipper's board unanimously turns down the unsolicited proposal, signaling confidence in its standalone strategy amid a firming market.

Diana Shipping Falters After Genco Publicly Rejects Takeover Bid
Mergers & Acquisitions
3w ago

Diana Shipping Falters After Genco Publicly Rejects Takeover Bid

Genco's board rebuked the unsolicited offer, citing significant undervaluation, high execution risk, and concerns over Diana's leverage and financing.

Comerica Jumps as Fed Grants Final Approval for Fifth Third Merger
Mergers & Acquisitions
3w ago

Comerica Jumps as Fed Grants Final Approval for Fifth Third Merger

The all-stock deal, valued at nearly $11 billion, clears its last regulatory hurdle, paving the way for the creation of a top-10 U.S. regional banking powerhouse.

Fifth Third Gets Final Fed Approval for Comerica Takeover
Mergers & Acquisitions
3w ago

Fifth Third Gets Final Fed Approval for Comerica Takeover

The nod from the central bank clears the last major hurdle for a deal that will create the ninth-largest U.S. bank, signaling a clearer path for large-scale financial mergers.

Genco Rejects Rival Diana Shipping's $890M Takeover Bid
Mergers & Acquisitions
3w ago

Genco Rejects Rival Diana Shipping's $890M Takeover Bid

Board dismisses unsolicited all-cash offer as undervaluing the company, signaling confidence in its standalone strategy as a larger fleet operator.

Genco Spurns Diana Shipping’s Takeover Bid, Vows Standalone Value
Mergers & Acquisitions
3w ago

Genco Spurns Diana Shipping’s Takeover Bid, Vows Standalone Value

Genco's board rejects the unsolicited cash offer, arguing its own strategy of low debt and high dividends will deliver superior shareholder returns.

AstraZeneca Acquires Modella AI to Bolster Oncology Drug Pipeline
Mergers & Acquisitions
3w ago

AstraZeneca Acquires Modella AI to Bolster Oncology Drug Pipeline

The $293 billion pharmaceutical giant deepens its commitment to artificial intelligence to accelerate the discovery of next-generation cancer therapies.

Semler Scientific Soars on $1.34B Bitcoin Merger Approval
Mergers & Acquisitions
3w ago

Semler Scientific Soars on $1.34B Bitcoin Merger Approval

Shareholders approve all-stock acquisition by Strive Inc., forging a new entity focused on a corporate Bitcoin treasury strategy.